HendelRCPatelMRKramerCMPoonMHendelRCCarrJCGerstadNAGillamLDHodgsonJMKimRJKramerCMLesserJRMartinETMesserJVRedbergRFRubinGDRumsfeldJSTaylorAJWeigoldWGWoodardPKBrindisRGHendelRCDouglasPSPetersonEDWolkMJAllenJMPatelMR: ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging. J Am Coll Cardiol2006;48(7):1475–1497.
2.
KajiSNasuMYamamuroATanabeKNagaiKTaniTTamitaKShiratoriKKinoshitaMSendaMOkadaYMoriokaS: Annular geometry in patients with chronic ischemic mitral regurgitation: Three-dimensional magnetic resonance imaging study. Circulation2005; 112 (9 Suppl):I409–414.
3.
SugengLMor-AviVWeinertLNielJEbnerCSteringer-MascherbauerRSchmidtFGaluschkyCSchummersGLangRMNesserHJ: Quantitative assessment of left ventricular size and function: Side-by-side comparison of real-time three-dimensional echocardiography and computed tomography with magnetic resonance reference. Circulation2006; 114(7):654–661.
4.
LaroseEGanzPReynoldsHGDorbalaSDi CarliMFBrownKAKwongRY: Right ventricular dysfunction assessed by cardiovascular magnetic resonance imaging predicts poor prognosis late after myocardial infarction. J Am Coll Cardiol2007;49(8):855–862.
5.
BodiVSanchisJLopez-LereuMPNunezJSanzRPalauPGomezCMoratalDChorroFJLlacerA: Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging. Heart2006; 92(12):1801–1807.
6.
SieversBElliottMDHurwitzLMAlbertTSKlemIRehwaldWGParkerMAJuddRMKimRJ: Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation2007;115(2):236–244.
7.
McCrohonJAMoonJCPrasadSKMcKennaWJLorenzCHCoatsAJPennellDJ: Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation2003;108(1):54–59.
8.
IkonenAEManninenHIVainioPHirvonenTPVanninenRLMatsiPJSoimakallioSHartikainenJE: Three-dimensional respiratory-gated coronary MR angiography with reference to X-ray coronary angiography. Acta Radiol2003;44(6):583–589.
9.
PaetschIJahnkeCWahlAGebkerRNeussMFleckENagelE: Comparison of dobutamine stress magnetic resonance, adenosine stress magnetic resonance, and adenosine stress magnetic resonance perfusion. Circulation2004;110(7):835–842.
10.
BreeDWollmuthJRCuppsBPKrockMDHowellsARogersJMoazamiNPasqueMK: Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy. Circulation2006;114 (1 Suppl):I33–36.
11.
JohnsonBDShawLJBuchthalSDMerzBairey CNKimHWScottKNDoyleMOlsonMBPepineCJDen HollanderJSharafBRogersWJMankadSForderJRKelseySFPohostGM: Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation2004;109(24):2993–2999.
12.
HudsmithLEPetersenSEFrancisJMRobsonMDNeubauerS: Normal human left and right ventricular and left atrial dimensions using steady state free precession magnetic resonance imaging. J Cardiovasc Magn Reson2005;7(5):775–782.
13.
SyedMAPatersonDIIngkanisornWPRhoadsKLHillJCannonRO3rdAraiAE: Reproducibility and inter-observer variability of dobutamine stress CMR in patients with severe coronary disease: Implications for clinical research. J Cardiovasc Magn Reson2005;7(5):763–768.
14.
SlomkaPJFienoDThomsonLFriedmanJDHayesSWGermanoGBermanDS: Automatic detection and size quantification of infarcts by myocardial perfusion SPECT: Clinical validation by delayed-enhancement MRI. J Nucl Med2005;46(5):728–735.
15.
HunoldPSchlosserTVogtFMEggebrechtHSchmermundABruderOSchulerWOBarkhausenJ: Myocardial late enhancement in contrast-enhanced cardiac MRI: Distinction between infarction scar and non-infarction-related disease. AJR. Am J Roentgenol2005;184(5):1420–1426.
16.
KuhlHPLipkeCSKrombachGAKatohMBattenbergTFNowakBHeussenNBueckerASchaeferWM: Assessment of reversible myocardial dysfunction in chronic ischaemic heart disease: Comparison of contrast-enhanced cardiovascular magnetic resonance and a combined positron emission tomography-single photon emission computed tomography imaging protocol. Eur Heart J2006;27(7):846–853.
17.
TarantiniGRazzoliniRCacciavillaniLBilatoCSaraisCCorbettiFMarraMPNapodanoMRamondoAIlicetoS: Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty. Am J Cardiol2006;98(8):1033–1040.
18.
SchwitterJNanzDKneifelSBertschingerKBuchiMKnuselPRMarincekBLuscherTFvon SchulthessGK: Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: A comparison with positron emission tomography and coronary angiography. Circulation. 103(18):2230–2235, 2001 May 8.
19.
BodiVSanchisJLopez-LereuMPLosadaANunezJPellicerMBertomeuVChorroFJLlacerA: Usefulness of a comprehensive cardiovascular magnetic resonance imaging assessment for predicting recovery of left ventricular wall motion in the setting of myocardial stunning. J Am Coll Cardiol2005;46(9):1747–1752.
20.
BoveCMDiMariaJMVorosSConawayMRKramerCM: Dobutamine response and myocardial infarct transmurality: Functional improvement after coronary artery bypass graftinginitial experience. Radiology2006;240(3):835–841.
21.
GutberletMFrohlichMMehlSAmthauerHHausmannHMeyerRSiniawskiHRufJPlotkinMDeneckeTSchnackenburgBHetzerRFelixR: Myocardial viability assessment in patients with highly impaired left ventricular function: Comparison of delayed enhancement, dobutamine stress MRI, end-diastolic wall thickness, and TI201—SPECT with functional recovery after revascularization. Eur Radiol2005;15(5):872–880.
22.
GelfandEVHughesSHauserTHYeonSBGoepfertLKissingerKVRofskyNMManningWJ: Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: Optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson2006;8(3):503–507.
23.
AraozPAGlocknerJFGcGeeKP: 3 Tesla MR imaging provides improved contrast in first-pass myocardial perfusion imaging over a range of gadolinium doses. J Cardiovasc Magn Reson2005;7:559–564.